文献速递肺外科

c-IA期肺癌肺叶、肺段与楔形切除的真实世界结局

Real-world outcomes of lobectomy, segmentectomy and wedge resection for the treatment of stage c-IA lung carcinoma.
PubMed 文献 · Eur J Cardiothorac Surg · 2024-01-01

未校正90天死亡率分别为1.6%、1.2%、1.1%(P=0.10);未校正5年OS分别为80%、78%、70%(P<0.0001)。多变量分析示楔形切除较肺叶切除总生存更差(AHR 1.23, 95%CI 1.03-1.47; P=0.021),肺段切除与肺叶切除无显著差异(1.08 [0.97-1.20]; P=0.162)。

要点

  • 楔形切除较肺叶切除90天死亡率相当但总生存更差(AHR 1.23, 95%CI 1.03-1.47; P=0.021)。
  • 肺段切除与肺叶切除总生存无显著差异(AHR 1.08 [0.97-1.20]; P=0.162)。
  • 倾向评分分析示楔形和肺段切除较肺叶切除90天死亡率无显著差异,但总生存更差。

核心结论

  • 楔形切除与肺叶切除相比90天死亡率相当但总生存更低。
  • 在真实世界环境中,各类亚肺叶切除可能不提供等效的肿瘤学效果。

研究设计与样本

  • 主要结局为90天死亡率和5年总生存估计,采用比例风险回归和倾向评分匹配校正患者、肿瘤和实践环境因素。

主要发现

  • 治疗分布为肺叶切除72.2%、肺段切除21.5%、楔形切除6.3%。
  • 未校正90天死亡率分别为1.6%、1.2%、1.1%(P=0.10)。
  • 未校正5年总生存分别为80%、78%、70%,组间生存曲线差异显著(P<0.0001)。
  • 多变量比例风险回归显示楔形切除较肺叶切除总生存更差(AHR 1.23, 95%CI 1.03-1.47; P=0.021),肺段切除与肺叶切除无显著差异(1.08 [0.97-1.20]; P=0.162)。
  • 三向倾向评分分析证实楔形切除和肺段切除较肺叶切除90天死亡率相似(HR 0.43; 95%CI 0.16-1.11; P=0.081 和 0.99; 0.48-2.10; P=0.998),但总生存更差(1.45; 1.13-1.86; P=0.003 和 1.31; 1-1.71; P=0.048)。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To determine safety and survival outcomes associated with lobectomy, segmentectomy and wedge resection for early-stage lung cancer by quiring the French population-based registry EPIdemiology in THORacic surgery (EPITHOR). METHODS: Retrospective analysis of 19 452 patients with stage c IA lung carcinoma who underwent lobectomy, segmentectomy or wedge resection between 2016 and 2022 with curative-intent. Main outcome measures were 90-day mortality and 5-year overall survival estimates. Proportional hazards regression and propensity score matching were used to adjust outcomes for key patient, tumour and practice environment factors. RESULTS: The treatment distribution was 72.2% for lobectomy, 21.5% for segmentectomy and 6.3% for wedge. Unadjusted 90-day mortality rates were 1.6%, 1.2% and 1.1%, respectively (P = 0.10). Unadjusted 5-year overall survival estimates were 80%, 78% and 70%, with significant inter-group survival curves differences (P < 0.0001). Multivariable proportional hazards regression showed that wedge was associated with worse overall survival [adjusted hazard ratio (AHR), 1.23 (95% confidence interval 1.03-1.47); P = 0.021] compared with lobectomy, while no significant difference was disclosed when comparing segmentectomy to lobectomy (1.08 [0.97-1.20]; P = 0.162). The three-way propensity score analyses confirmed similar 90-day mortality rate for wedge resection and segmentectomy compared with lobectomy (hazard ratio: 0.43; 95% confidence interval 0.16-1.11; P = 0.081 and 0.99; 0.48-2.10; P = 0.998, respectively), but poorer overall survival (1.45; 1.13-1.86; P = 0.003 and 1.31; 1-1.71; P = 0.048, respectively). CONCLUSIONS: Wedge resection was associated with comparable 90-day mortality but lower overall survival when compared to lobectomy. Overall, all types of sublobar resections may not offer equivalent oncologic effectiveness in real-world settings.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Thomas PA, Seguin-Givelet A, Pages PB, et al. Real-world outcomes of lobectomy, segmentectomy and wedge resection for the treatment of stage c-IA lung carcinoma. Eur J Cardiothorac Surg. 2024. PMID: 38917411. doi:10.1093/ejcts/ezae251

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。